Aqr Capital Management LLC Tricida, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $170,965 - $273,224	20,090 New	20,090 $211,000
Q2 2020 Aug 17, 2020	SELL	$21.21 - $31.55 $270,978 - $403,082	-12,776 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $30,188 - $62,309	1,638 Added 14.71%	12,776 $281,000
Q4 2019 Feb 14, 2020	BUY	$29.6 - $43.71 $329,684 - $486,841	11,138 New	11,138 $420,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.